Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials (Q37624213)
Jump to navigation
Jump to search
scientific article published on 28 October 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials |
scientific article published on 28 October 2009 |
Statements
1 reference
8 references
Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials (English)
1 reference
7 references
Eliano Navarese
1 reference
Giuseppe De Luca
1 reference
Paolo Marino
1 reference
28 October 2009
1 reference
1 November 2009
8 references
19 March 2019
22 March 2019
17 June 2019
25 June 2019
31 July 2019
19 September 2019
15 December 2019
28 April 2021
9 references
19 March 2019
22 March 2019
17 June 2019
25 June 2019
31 July 2019
19 September 2019
15 December 2019
28 April 2021
2705-2713
1 reference
8 references
19 March 2019
22 March 2019
17 June 2019
25 June 2019
31 July 2019
19 September 2019
15 December 2019
28 April 2021
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference